Cargando…
Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth
PURPOSE: Cystic fibrosis (CF), caused by pathogenic variants in the CF transmembrane conductance regulator (CFTR), affects multiple organs including the exocrine pancreas, which is a causal contributor to cystic fibrosis–related diabetes (CFRD). Untreated CFRD causes increased CF-related mortality w...
Ejemplares similares
-
Correction to: Cystic fibrosis–related diabetes onset can be predicted using biomarkers measured at birth
por: Lin, Yu-Chung, et al.
Publicado: (2021) -
Genetic evidence supports the development of SLC26A9 targeting therapies for the treatment of lung disease
por: Gong, Jiafen, et al.
Publicado: (2022) -
High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification
por: Mastromatteo, Scott, et al.
Publicado: (2022) -
Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics
por: Strug, Lisa J., et al.
Publicado: (2016) -
Immunoreactive trypsinogen levels in newborn screened infants with an inconclusive diagnosis of cystic fibrosis
por: Ooi, Chee Y., et al.
Publicado: (2019)